bioAffinity Technologies ...
(BIAFW)
undefined
undefined%
At close: undefined
0.80
167.20%
Pre-market Nov 19, 2024, 10:19 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 2.53M | 4.80K | n/a | n/a | n/a |
| Cost of Revenue | 1.74M | 467.00 | 4.82K | 22.24K | 40.28K |
| Gross Profit | 791.62K | 4.34K | -4.82K | -22.24K | -40.28K |
| Operating Income | -7.97M | -4.01M | -2.21M | -2.60M | -3.09M |
| Interest Income | 122.13K | 46.71K | 424.00 | 1.07K | 2.78K |
| Pretax Income | -7.92M | -8.15M | -6.32M | -7.27M | -3.30M |
| Net Income | -7.94M | -8.15M | -6.33M | -7.27M | -3.31M |
| Selling & General & Admin | 6.79M | 2.73M | 880.77K | 994.34K | 1.20M |
| Research & Development | 1.72M | 1.29M | 1.33M | 1.61M | 1.85M |
| Other Expenses | 249.59K | -1.87M | 724.93K | -4.28M | n/a |
| Operating Expenses | 8.76M | 4.02M | 2.21M | 2.60M | 3.05M |
| Interest Expense | 37.13K | 2.53M | 1.00M | 382.17K | 214.83K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 10.51M | 4.02M | 2.21M | 2.60M | 3.09M |
| Income Tax | 20.99K | 2.46K | 1.95K | 2.75K | 3.20K |
| Shares Outstanding (Basic) | 8.75M | 4.50M | 7.38M | 7.38M | 7.38M |
| Shares Outstanding (Diluted) | 8.75M | 4.50M | 7.38M | 7.38M | 7.38M |
| EPS (Basic) | -0.91 | -1.81 | -0.86 | -0.99 | -0.45 |
| EPS (Diluted) | -0.91 | -1.81 | -0.86 | -0.99 | -0.45 |
| EBITDA | -7.63M | -5.61M | -2.20M | -6.86M | -3.05M |
| Depreciation & Amortization | 249.59K | 10.18K | 4.82K | 22.24K | 40.28K |